Myeloma - A Beginner’s Hope for Setting Up a New Transplant Centre in Tier-2 City in India

Authors

  • Subbaiah Ramanathan Consultant Clinical Haematologist, Kauvery hospital, Trichy, Tamilnadu, India
  • Prabhakaran Shanka Consultant in Transfusion Medicine, Kauvery hospital, Trichy, Tamilnadu, India
  • Anand Vikas Anand Vikas, Pathologist, Neuberg Ehrlich labs, Bengaluru, India
  • Thilagavathy Consultant Microbiologist, Kauvery hospital, Trichy, Tamilnadu, India

Abstract

Most of the haemopoietic stem cell transplant (HSCT) centres are established in tier-1 cities (population of 1 million and above). Establishing a HSCT centre in a tier-2 city (0.5 to less than 1 million population) remains a challenge for a new transplant physician (immediately after qualifying a residency programme) who starts his clinical practice especially in a private sector hospital. In such a scenario, Myeloma remains the most common disorder to be taken up for a HSCT by a new transplant physician and a new HSCT team. Here we share our experience in establishing a new and the first HSCT in Tiruchirappalli (a tier-2 city in Tamil Nadu, South India). Myeloma was chosen as the first disorder to be transplanted here, bringing hope to the physician, new HSCT team as well as patients in this part of the country.

Downloads

Published

2023-09-25

How to Cite

Subbaiah Ramanathan, Prabhakaran Shanka, Anand Vikas, & Thilagavathy. (2023). Myeloma - A Beginner’s Hope for Setting Up a New Transplant Centre in Tier-2 City in India. Kauverian Medical Journal, 2023(2), 10–12. Retrieved from https://kauverianjournal.com/index.php/research/article/view/41

Issue

Vol. 2023 No. 2: September

Section

Articles